vs
Sprinklr, Inc.（CXM）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Sprinklr, Inc.的季度营收约是REPLIGEN CORP的1.1倍（$219.1M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 1.3%，领先5.4%），REPLIGEN CORP同比增速更快（13.6% vs 9.2%），Sprinklr, Inc.自由现金流更多（$19.8M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 6.2%）
Sprinklr是美国的一家SaaS企业，专注于客户体验管理（CXM）平台研发。其同名产品整合了社媒营销、社交广告、内容管理、团队协作、员工倡导、客户服务、社媒调研与监测等多类应用模块，为企业提供全链路的客户体验管理解决方案。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CXM vs RGEN — 直观对比
营收规模更大
CXM
是对方的1.1倍
$197.9M
营收增速更快
RGEN
高出4.5%
9.2%
净利率更高
RGEN
高出5.4%
1.3%
自由现金流更多
CXM
多$2.2M
$17.6M
两年增速更快
RGEN
近两年复合增速
6.2%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.1M | $197.9M |
| 净利润 | $2.9M | $13.3M |
| 毛利率 | 66.4% | 52.5% |
| 营业利润率 | 5.3% | 9.0% |
| 净利率 | 1.3% | 6.7% |
| 营收同比 | 9.2% | 13.6% |
| 净利润同比 | -72.2% | 143.9% |
| 每股收益（稀释后） | $0.01 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CXMRGEN
| Q4 25 | $219.1M | $197.9M | ||
| Q3 25 | $212.0M | $188.8M | ||
| Q2 25 | $205.5M | $182.4M | ||
| Q1 25 | $202.5M | $169.2M | ||
| Q4 24 | $200.7M | $174.1M | ||
| Q3 24 | $197.2M | $154.9M | ||
| Q2 24 | $196.0M | $154.1M | ||
| Q1 24 | $194.2M | $151.3M |
净利润CXMRGEN
| Q4 25 | $2.9M | $13.3M | ||
| Q3 25 | $12.6M | $14.9M | ||
| Q2 25 | $-1.6M | $14.9M | ||
| Q1 25 | $98.7M | $5.8M | ||
| Q4 24 | $10.5M | $-30.3M | ||
| Q3 24 | $1.8M | $-654.0K | ||
| Q2 24 | $10.6M | $3.3M | ||
| Q1 24 | $21.1M | $2.1M |
毛利率CXMRGEN
| Q4 25 | 66.4% | 52.5% | ||
| Q3 25 | 68.2% | 53.2% | ||
| Q2 25 | 69.5% | 50.0% | ||
| Q1 25 | 71.0% | 53.6% | ||
| Q4 24 | 71.2% | 26.1% | ||
| Q3 24 | 72.6% | 50.0% | ||
| Q2 24 | 73.9% | 49.8% | ||
| Q1 24 | 75.5% | 49.5% |
营业利润率CXMRGEN
| Q4 25 | 5.3% | 9.0% | ||
| Q3 25 | 7.7% | 8.9% | ||
| Q2 25 | -0.9% | 7.6% | ||
| Q1 25 | 5.2% | 3.9% | ||
| Q4 24 | 3.9% | -17.7% | ||
| Q3 24 | -0.0% | -5.1% | ||
| Q2 24 | 2.9% | 1.0% | ||
| Q1 24 | 9.5% | 1.3% |
净利率CXMRGEN
| Q4 25 | 1.3% | 6.7% | ||
| Q3 25 | 5.9% | 7.9% | ||
| Q2 25 | -0.8% | 8.2% | ||
| Q1 25 | 48.7% | 3.4% | ||
| Q4 24 | 5.2% | -17.4% | ||
| Q3 24 | 0.9% | -0.4% | ||
| Q2 24 | 5.4% | 2.2% | ||
| Q1 24 | 10.9% | 1.4% |
每股收益（稀释后）CXMRGEN
| Q4 25 | $0.01 | $0.24 | ||
| Q3 25 | $0.05 | $0.26 | ||
| Q2 25 | $-0.01 | $0.26 | ||
| Q1 25 | $0.35 | $0.10 | ||
| Q4 24 | $0.04 | $-0.55 | ||
| Q3 24 | $0.01 | $-0.01 | ||
| Q2 24 | $0.04 | $0.06 | ||
| Q1 24 | $0.07 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $189.6M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $558.1M | $2.1B |
| 总资产 | $1.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CXMRGEN
| Q4 25 | $189.6M | $767.6M | ||
| Q3 25 | $125.4M | $748.7M | ||
| Q2 25 | $126.4M | $708.9M | ||
| Q1 25 | $145.3M | $697.2M | ||
| Q4 24 | $93.2M | $757.4M | ||
| Q3 24 | $119.1M | $784.0M | ||
| Q2 24 | $126.8M | $809.1M | ||
| Q1 24 | $164.0M | $780.6M |
总债务CXMRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CXMRGEN
| Q4 25 | $558.1M | $2.1B | ||
| Q3 25 | $543.4M | $2.1B | ||
| Q2 25 | $639.8M | $2.1B | ||
| Q1 25 | $612.1M | $2.0B | ||
| Q4 24 | $497.0M | $2.0B | ||
| Q3 24 | $469.0M | $2.0B | ||
| Q2 24 | $610.9M | $2.0B | ||
| Q1 24 | $679.7M | $2.0B |
总资产CXMRGEN
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $1.1B | $2.9B | ||
| Q2 25 | $1.2B | $2.9B | ||
| Q1 25 | $1.2B | $2.9B | ||
| Q4 24 | $970.3M | $2.8B | ||
| Q3 24 | $983.8M | $2.8B | ||
| Q2 24 | $1.1B | $2.9B | ||
| Q1 24 | $1.2B | $2.8B |
负债/权益比CXMRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $19.8M | $17.6M |
| 自由现金流率自由现金流/营收 | 9.0% | 8.9% |
| 资本支出强度资本支出/营收 | 0.1% | 4.1% |
| 现金转化率经营现金流/净利润 | 6.87× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $142.3M | $93.9M |
8季度趋势，按日历期对齐
经营现金流CXMRGEN
| Q4 25 | $20.0M | $25.7M | ||
| Q3 25 | $34.8M | $48.1M | ||
| Q2 25 | $83.8M | $28.6M | ||
| Q1 25 | $5.4M | $15.0M | ||
| Q4 24 | $9.2M | $39.2M | ||
| Q3 24 | $21.3M | $49.3M | ||
| Q2 24 | $41.7M | $42.2M | ||
| Q1 24 | $17.3M | $44.7M |
自由现金流CXMRGEN
| Q4 25 | $19.8M | $17.6M | ||
| Q3 25 | $34.4M | $43.4M | ||
| Q2 25 | $83.5M | $21.5M | ||
| Q1 25 | $4.6M | $11.4M | ||
| Q4 24 | $8.2M | $33.6M | ||
| Q3 24 | $19.8M | $42.3M | ||
| Q2 24 | $39.2M | $37.4M | ||
| Q1 24 | $15.2M | $36.4M |
自由现金流率CXMRGEN
| Q4 25 | 9.0% | 8.9% | ||
| Q3 25 | 16.2% | 23.0% | ||
| Q2 25 | 40.6% | 11.8% | ||
| Q1 25 | 2.3% | 6.8% | ||
| Q4 24 | 4.1% | 19.3% | ||
| Q3 24 | 10.1% | 27.3% | ||
| Q2 24 | 20.0% | 24.3% | ||
| Q1 24 | 7.9% | 24.0% |
资本支出强度CXMRGEN
| Q4 25 | 0.1% | 4.1% | ||
| Q3 25 | 0.2% | 2.5% | ||
| Q2 25 | 0.1% | 3.9% | ||
| Q1 25 | 0.4% | 2.1% | ||
| Q4 24 | 0.5% | 3.2% | ||
| Q3 24 | 0.8% | 4.5% | ||
| Q2 24 | 1.3% | 3.1% | ||
| Q1 24 | 1.1% | 5.5% |
现金转化率CXMRGEN
| Q4 25 | 6.87× | 1.93× | ||
| Q3 25 | 2.76× | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | 0.05× | 2.57× | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 11.58× | — | ||
| Q2 24 | 3.92× | 12.70× | ||
| Q1 24 | 0.82× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CXM
| License And Service | $190.3M | 87% |
| Professional Services | $28.8M | 13% |
RGEN
暂无分部数据
